Skip to content
healthcare.dev

HYDROXYUREA

NDC 67184-0607, HYDROXYUREA, capsule, from Qilu Pharmaceutical Co., Ltd..

Product NDC
67184-0607
Status
Listed
Labeler
Qilu Pharmaceutical Co., Ltd.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA218021
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0607 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HYDROXYUREA500 mg/1

Pharmacologic classes

Antimetabolite [EPC]; Urea [CS]

Package NDCNDC-11Package
67184-0607-167184060701100 CAPSULE in 1 BOTTLE (67184-0607-1)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4cd244d4-bd4a-41c8-b072-c2135787d412

Use it

Look up 67184-0607 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0607 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 67184-0607. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.